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ABSTRACT
Background:  Research implicates psychological factors in low uptake 
of lung cancer screening. We developed and psychometrically tested a 
standardised measure of these psychological determinants in prepara-
tion for a prospective, longitudinal cohort study of screening uptake.
Methods:   Leventhal’s Common-Sense Model of Self-Regulation of 
Health and Illness provided the theoretical framework to generate the 
initial item pool. Items were refined during expert review and cognitive 
interviews which tested for face validity, redundancy, acceptability and 
comprehensibility. An online survey piloted the refined pool with 1500 
current and former (quit ≤ 15 years) smokers aged 55–80. The response 
distributions, internal reliability and factor structure determined the 
final retained constructs. Regression analyses examined these con-
structs’ associations with screening intention, smoking status and 
demographics.
Results:  The final measure included seven factor-derived subscales (con-
sequences, personal control, treatment control, illness coherence, emo-
tional representation, behavioural response and appraisal, risk perception) 
with Cronbach’s alphas ranging from 0.59 to 0.91 and four single-item 
questions (response efficacy for smoking cessation, treatment intention, 
perceived stigma and lung cancer survival). Most constructs were asso-
ciated with smoking status and screening intention (p’s < .05).
Conclusions:   The Self-Regulatory Questionnaire for Lung Cancer 
Screening (SRQ-LCS) is an acceptable, reliable and valid measure for 
investigating the psychological determinants of screening uptake.
Introduction
Lung cancer is one of the leading causes of premature mortality in the UK and is highly 
socially graded (Iyen-Omofoman et al., 2011). A recent analysis estimated that 47% of lung 
cancer deaths in England would be avoided if all groups had the same risk as those in the 
highest deprivation decile (Lewer et  al., 2020). Effective tobacco control measures and 
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smoking cessation support are key to reducing incidence, but equitable early diagnosis 
strategies are also needed to improve survival. Screening high-risk adults (aged 55–80 with 
a significant and recent smoking history) for lung cancer using low-dose computed tomog-
raphy (LDCT) significantly reduces mortality by finding the disease at an early and treatable 
stage (de Koning et  al., 2020; National Lung Screening Trial Research Team et al., 2011). 
Consequently, screening is recommended by the US Preventive Services Task Force (USPSTF) 
(Moyer, 2014) and is being piloted in England through NHS England’s Targeted Lung Health 
Check Programme. However, socioeconomic and smoking-related inequalities in participa-
tion have consistently been observed in the UK and internationally whereby lower socio-
economic position (SEP) and current smoking status predict lower uptake (Hestbech et al., 
2011; McRonald et  al., 2014; National Lung Screening Trial Research Team et al., 2010). 
Critically, this reduces the extent to which this early diagnosis strategy is reaching those at 
highest risk, undermining the population impact on lung cancer mortality.
The determinants of low uptake of LDCT lung screening in high-risk groups are likely to 
include complex structural and environmental inequalities which determine the resources, 
stressors, opportunities and illness experiences that ultimately shape individual differences 
in beliefs about health (von Wagner et al., 2011). These structural inequalities are critical to 
address, but research studies implicate the resulting psychological factors as potentially mod-
ifiable targets for intervention at the individual level. For example, low SEP and current smok-
ing status have been associated with negative perceptions and beliefs about lung cancer 
outcomes such as fatalism and low perceived quality of life (Patel et al., 2012; Quaife et al., 
2018, 2016; Smits et al., 2018), adverse emotional and social responses to perceived risk such 
as cancer worry, fear and perceived stigma (Ali et al., 2015; Carter-Harris et al., 2017; Quaife 
et al., 2016), and low perceived personal benefit of screening such as low response efficacy 
of early diagnosis and treatment (Patel et al., 2012; Quaife et al., 2018, 2016; Smits et al., 2018). 
Limitations of these studies include cross-sectional design and heterogeneity of measures 
used. However, together they highlight potentially important patterns of discordance between 
lay understanding of lung cancer and the medical model of screening; specifically, where lung 
cancer is perceived as a disease for which screening is ill-suited and unlikely to be effective 
for long-term smokers. An example is the perception that lung cancer screening is more likely 
to benefit those at lower risk (younger adults with a shorter smoking history) than those at 
higher risk (older adults with long-term smoking histories) when the opposite is true (Moyer, 
2014). Similarly, in qualitative research with high-risk groups, some participants believed that 
treatment for lung cancer involves removing the entire affected lung (Quaife et al., 2016). 
However, surgery for early stage treatment is usually targeted within one lobe. Related to this, 
perceptions of low efficacy have been attributed to smoking cessation in older age (Quaife 
et al., 2016), when smoking cessation reduces risk of lung cancer mortality at all ages (Peto 
et al., 2000), improves lung cancer survival (Tammemagi et al., 2004), reduces risk of recurrence 
(Parsons et al., 2010) and lessens post-operative complications (Mason et al., 2009).
Leventhal’s et al. (2003) Common-Sense Model of Self-Regulation of Health and Illness 
(SRM) provides a useful framework for conceptualising these discordant perceptions and 
hypothesising how they might affect screening participation. The model posits that incon-
gruence between an individual’s understanding of an illness, their emotional response and 
the relevant protection behaviour, undermines motivation to engage in that behaviour. This 
includes an individual’s cognitive representation of the illness (such as its consequences, 
treatment and causes), their emotional reaction, and the behaviours available to control 
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both the illness (e.g. screening) and emotional reaction to it (e.g. avoidance). It also includes 
appraisal perceptions of how well (or not) these behavioural responses work in controlling 
the illness or emotional response. Originally developed to understand non-adherence to 
medication for chronic disease, the SRM has good predictive validity across diverse types of 
illness (Leventhal et al., 1992; Phillips et al., 2012). There is also evidence to support its appli-
cation to cancer control among high-risk groups, implicating lay representations of perceived 
risk (Cameron, 2008; Kelly et al., 2005), controllability (Sullivan et al., 2010) and causal beliefs 
(Bishop et al., 2005) in adherence to cancer prevention behaviours including colorectal cancer 
screening, smoking abstinence and sunscreen use.
Previous studies of the psychological determinants of lung screening participation (Ali et al., 
2015; Carter-Harris et al., 2017; Patel et al., 2012; Quaife et al., 2018, 2016; Smits et al., 2018) 
have used heterogeneous measures, making comparisons between studies difficult. Our pri-
mary aim, therefore, was to use the SRM framework to develop and validate a standardised 
measure of psychological determinants of screening participation by high-risk individuals, in 
preparation for a prospective, longitudinal cohort study of lung cancer screening uptake 
behaviour. Our secondary aims were to explore the demographic and smoking-related cor-
relates of each of the measure’s constructs, and their associations with intention to be screened.
Materials and methods
Item generation
We used the SRM as a framework to generate the initial item pool for constructs hypothesised 
to affect lung cancer screening participation by high-risk asymptomatic individuals (see Figure 1). 
A key source of illness representation and emotional representation items was the Revised 
Illness Perception Questionnaire (IPQ-R (Moss-Morris et al., 2002)), which was developed to 
Figure 1. leventhal’s et al. (2003) common-sense Model of self-Regulation of health and Illness (sRM) 
applied to uptake of lung cancer screening by high-risk individuals.
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measure these constructs in the context of patients with chronic illness. This includes eight 
components: identity, timeline, consequences, personal control, treatment control, illness coher-
ence, emotional representations and causes. Additional items assessing each of the SRM con-
structs were mostly drawn from existing electronically available research papers and surveys: 
risk perceptions [7 items (Ferrer et al., 2016; Kaufman et al., 2015; Lerman et al., 1993)], repre-
sentation of risk of lung cancer mortality [36 items (Broadbent et al., 2006; HINTS, 2015; Moss-
Morris et al., 2002; Simon et al., 2012)], behavioural responses for controlling risk of lung cancer 
mortality [7 items (Kotz et al., 2013)], representations of emotional reaction to risk of lung cancer 
mortality [15 items (Cataldo et al., 2011; Ferrer et al., 2016; Kaufman et al., 2015; Lerman et al., 
1993; Marlow & Wardle, 2014; Moss-Morris et al., 2002)], behavioural responses for emotion 
control [16 items (Carver, 1997; HINTS, 2015; Quaife et al., 2016)], and appraisal of behavioural 
responses for risk and emotion [13 items, (HINTS, 2015; Jarvis et al., 2003; Joseph et al., 2018; 
Kaufman et al., 2015; Quaife et al., 2016; Silvestri et al., 2007)]. Minor adaptations were made to 
some items in order to i) ensure the disease referred to was lung cancer, ii) ensure the question 
was suited to both current and former smokers, or had variations to accommodate each smoking 
status, and iii) anchor questions to respondents’ perceptions of themselves unless the question 
concerned perceptions of someone with lung cancer for which items were phrased in the third 
person. Some original items were also created for five of the constructs (personal control, treat-
ment control, illness coherence, emotional representations, and behavioural responses for 
controlling risk of lung cancer mortality). This resulted in a pool of 94 items in total.
Item testing and refinement
A working group (n = 7) with expertise in Behavioural Science, Cancer Screening, Questionnaire 
Design and Tobacco Control assessed the items for face validity and potential redundancy. 
Cognitive interviews (n = 7) were then carried out by SLQ and CS with current and former 
smokers (quit ≤11 years) aged 59–71 years who had diverse educational backgrounds, includ-
ing no qualifications (n = 1), CSE’s or O’levels (n = 3), further education (n = 2) and a degree 
(n = 1). These inclusion criteria aimed to ensure interviewees had characteristics broadly 
reflecting eligibility for LDCT lung cancer screening according to USPSTF criteria (Moyer, 
2014), as well as varying levels of literacy. A think-aloud (Campanelli, 1997) approach was 
used where participants worked through each question, vocalising their responses including 
the reasoning behind them, any confusion or difficulties with comprehension, and any issues 
with acceptability. These were followed by pre-determined probes specified within a 
semi-structured topic guide. These probed participants about item clarity and comprehen-
sibility, acceptability, ease of answering, suggestions for alternative item phrasing, item 
redundancy and preferences where there was more than one item option. Participants’ reac-
tions to, suggestions for and perceptions of, each item were recorded informally within an 
unstructured matrix. Items perceived as unacceptable or unclear by at least one participant 
were removed or rephrased, respectively. Where there was more than one variation in phras-
ing for an item, the item preferred by a clear majority of participants was selected.
Online survey
An online survey was carried out in October 2018 to pilot the refined item pool and collect 
data for psychometric analysis. The survey also collected information on participants’ 
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demographic characteristics (age, gender, ethnicity, marital status) and smoking status using 
a question adapted from the Awareness and Beliefs about Cancer (ABC) measure (Simon 
et  al., 2012) (‘Do you smoke cigarettes at all these days, including hand-rolled ones?). 
Socioeconomic position (SEP) was measured using three questions (highest level of educa-
tion, housing tenure and vehicle ownership). The responses to these questions were com-
bined to create an individual-level index ranging from zero to four; an approach used 
previously and shown to be associated with neighbourhood level measures of SEP and 
health behaviours, including cancer screening uptake (Robb et al., 2009; Wardle et al., 1999, 
2004). Participants were also asked about their intentions to be screened for lung cancer (‘If 
you were offered a CT scan of your lungs to check for the early signs of lung cancer, would 
you take up the offer?’) and their willingness to have surgery in the hypothetical event that 
they had early stage lung cancer (‘If I had early stage lung cancer, I would want to have the 
recommended surgery’).
Participants were recruited by a third-party company (Research Now Survey Sampling 
International) from diverse panels of members of the public who had previously indicated 
willingness to take part in surveys. Individuals were eligible to take part if they lived in 
England, were aged 55–80 years and were either current or former (quit ≤15 years ago) daily 
tobacco smokers. A quota was applied to ensure even numbers of each smoking status were 
recruited. Potential participants were presented with an information screen describing the 
study and participants’ rights. Throughout the survey, the order of questions was rotated at 
random to reduce response bias due to order effects. A nominal financial incentive was 
provided conditional on the participant completing the survey to reduce attrition. The time 
taken to complete the survey was actively tracked for each participant. Data were excluded 
for individuals who completed the survey in an implausibly short time.
The survey was ‘soft-launched’ with a smaller sub-sample (n = 167) of participants for quality 
assurance purposes and to check response distributions (see Supplementary Table 1). 
Following further minor refinements to the wording of 14 items and the addition of 10 items 
which used alternative phrasing, the final survey was carried out with a larger sample 
(n = 1333).
Psychometric analyses
Four stages of psychometric analyses were carried out to statistically test item response, 
validity and internal reliability. First, descriptive frequencies were calculated to examine the 
variation in response distributions and proportions of missing data (‘don’t know’ responses). 
Second, the discriminant validity of each item was tested in relation to smoking status (cur-
rent vs. former), SEP, and intention to take part in LDCT lung cancer screening (intenders vs. 
non-intenders) using chi square analysis. While we were primarily interested in a measure 
that predicted screening uptake, uptake has been consistently lower among those of a 
current smoking status and low SEP. Therefore, we wanted to prioritise items that discrimi-
nated by these factors where possible. Principal Components Analysis (PCA) using varimax 
rotation was run to explore the validity of each proposed construct and to reduce the number 
of constructs, and as a consequence items, within the final measure. Items measuring smok-
ing cessation, intention to be screened and intention to have treatment were excluded from 
the PCA. This was because they were intended as single item measures (intention items) or 
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because they were predominantly answerable by either former or current smokers (smoking 
cessation items). Finally, the internal reliability of the items within each extracted PCA com-
ponent was assessed using Cronbach’s alpha coefficients and item-total correlations.
Criteria for item reduction
The results of the psychometric analyses informed the selection of items for the final measure. 
Specifically, the criteria were: 1) item must load (>0.4) exclusively on one of the extracted 
components from PCA, 2) maximum of three items per construct (to create a brief scale for 
planned prospective study), 3) item must discriminate by screening intention, and 4) the 
psychometric properties of individual items (response distribution, missing and discriminant 
validity) should be prioritised when their impact on internal reliability statistics for each 
component (difference in Cronbach’s alpha/item-total correlations) are minor.
Analyses of final measure
T-Tests and ANOVA were used to explore differences in mean scores for each sub-scale by 
demographic factors and smoking status. Multivariable linear regression analyses were used 
to test whether each of the demographic characteristics and smoking status were inde-
pendently associated with the individual sub-scales and single-item constructs. Logistic 
regression analyses were then carried out to explore whether these were associated with 
intention to be screened for lung cancer. These included both unadjusted models and models 
adjusted for demographic characteristics and smoking status.
Ethics
University College London’s Research Ethics Committee granted approval for the cognitive 
interviews (5210/003) and survey data collection (5210/004).
Results
Item testing and refinement
Of the 94 items in the initial item pool, 28 were removed after review by the expert working 
group due to redundancy or low face validity. Minor modifications were also made to the 
phrasing of some items to improve clarity and face validity. This included removing items 
measuring the identity, timeline and cause components. Similar to Lancastle et al.’s (2011) 
adapted measure for ovarian cancer risk, the identity (symptom presence) and causes com-
ponents were excluded so as not to cause concern among disease-free, high-risk respon-
dents. The timeline component was excluded because unlike symptoms of chronic illness, 
there are no symptoms of risk which vary over time. This left 66 items for cognitive testing. 
Following the cognitive interviews, 13 items were removed; including two items perceived 
as redundant, four items perceived to have low acceptability, and seven items which did not 
make sense to participants in the context of lung cancer risk. These latter seven were adapted 
from the brief COPE measure (Carver, 1997), which were intended to measure behavioural 
responses for controlling one’s emotional reaction to risk of lung cancer mortality. Further 
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minor revisions were made to the phrasing of 17 items to improve readability. Following the 
survey soft launch (n = 167; Supplementary Table 1), further refinements were made to the 
wording of 14 items and 11 alternatively phrased versions of existing items were added 
which aimed to improve response distribution. This resulted in a total of 64 items to be tested.
Online survey
Participant characteristics
Table 1 presents the sample characteristics overall and by smoking status. Mean age of the 
sample was 64.6 years (range 55–80) and there was an even split by gender and smoking 
status. The majority of the sample reported a White ethnic background (98.3%), being mar-
ried or cohabiting (64.1%), and not being in paid employment (67.8%) predominantly due 
to retirement (52.9%). There was good representation across the five SEP groups, with the 
exception of the lowest SEP group which was merged with the next lowest SEP group for 
further analyses. With regards to smoking history, participants reported starting smoking 
at age 16.7 years on average, and (among former smokers) stopping aged 50.0. Tobacco 
dependence was high among current smokers, with three quarters (77.8%) reporting smok-
ing within 30 minutes of waking.
Psychometric analyses: response variation and discriminant validity
Supplementary Table 2 summarises the variation in response and discriminant validity for each 
item among the full sample (n = 1333). Twelve of the items had a skewed response distribution 
indicating potential ceiling effects and 18 items had a high (≥10%) ‘don’t know’ response rate. 
However, nearly all (60 items) discriminated by intention to be screened for lung cancer. The 
majority (34 items) discriminated by smoking status with the exception of the illness coherence 
and emotional representation sub-scales, where only the lung cancer worry and perceived 
stigma items discriminated. Far fewer (10 items) discriminated by socioeconomic position.
Findings from Principal Components Analysis (PCA) suggested a seven-component model, 
which was interpreted from both the point of inflexion on a scree plot and by retaining 
components with eigenvalues greater than 1 (Kaiser’s criterion, 1960). Five iterations of PCA 
were run, beginning with 57 items and excluding 25 items found to have either low item-
to-total correlations (>0.3), low communality, or to cross-load onto more than one compo-
nent. In total, 32 items loaded strongly (>0.4) onto one of the seven components and these 
factor loadings are presented in Table 2. Of these, a further 11 items were excluded because 
they contributed relatively little to the reliability of their respective sub-scale when compared 
with other items (as indicated by Cronbach’s alpha if deleted values and item-total correlation 
coefficients, see Table 2). Final item selection to create seven three-item extracted compo-
nents was based on the pre-specified a priori criteria (see Methods).
Retained items and constructs for the final measure
Supplementary Table 3 presents the items and constructs for the final measure. The con-
structs measured by each of the seven subscales were interpreted to be: four illness repre-
sentation components (consequences, personal control, treatment control, illness coherence), 
one emotional representation component, one behavioural response and appraisal com-
ponent (combining illness and emotion control behaviours), and one risk perception com-
ponent. Scores for each sub-scale, were created by summing responses to each item (e.g. 
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1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly 
agree) using reverse coding where relevant. Higher scores denoted either higher levels of 
the construct (higher perceived personal control, treatment control, coherence and per-
ceived risk) or more positive perceptions (of consequences, emotional representations, 
behavioural control and appraisal).
In addition, four single item questions were retained: two which had not been included in 
the PCA as described in the Methods (response efficacy for smoking cessation and intention 
to be treated for early stage lung cancer), and two which were included in the PCA but did not 
load strongly (<0.4) onto one of the components (perceived stigma and lung cancer survival).
Associations between demographic factors, smoking status and sub-scale scores
Table 2 presents the unadjusted mean scores on each factor-derived sub-scale for each demo-
graphic and smoking status group, and the mutually adjusted linear regression coefficients. 
Table 1. Demographic and smoking characteristics of the sample (n = 1333).


















Age, mean (SD) 64.6 (6.2) 63.1 (5.8) 66.2 (6.3)




















































Not working due to long-term sickness




























Age started smoking daily, mean (SD) 16.7 (4.2) 17.0 (4.3) 16.5 (4.1)
Age stopped smoking, mean (SD)a – – 50.0 (10.4)
Tobacco consumption (current or past), mean (SD)
cigarettes per day
























Notes. Per cent totals may not sum due to rounding.
aFormer smokers only (n = 669).
bcurrent smokers only (n = 664).
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Relative to men, women had statistically significantly lower perceived personal control 
(M:10.89 vs. 11.31; ß: –0.40, p<.001), more negative emotional representations (M:7.05 vs. 
7.76; ß: –0.68, p<.001) and higher risk perceptions (M: 7.83 vs. 7.20; ß:0.47, p<.001). Older age 
was associated with lower perceived risk (ß: –0.03, p<.01) and more positive emotional rep-
resentations (ß:0.01, p<.01). Marital status was only associated with the coherence sub-scale 
in adjusted analyses, with those who were not married or cohabiting reporting higher coher-
ence than those in the married/cohabiting group (M:9.25 vs. 8.98; ß:0.41, p<.05). Higher SEP 
was associated with greater perceived coherence across all sub-groups (e.g. group four vs. 
group zero/one: M:9.18 vs. 8.63; ß:0.78, p<.01), and with increased personal control for groups 
three and four compared with group zero/one (M:11.22 & 11.19 vs. 10.76; ß:0.45, p<.05 & 
ß:0.53, p<.05). There were no consistent associations with SEP for any of the other sub-scales. 
Smoking status was associated with scores on five of the seven sub-scales. Compared with 
former smokers, current smokers perceived more positive consequences (M:4.73 vs. 4.42; 
ß:0.31, p<.001), lower personal control (M:10.90 vs. 11.30; ß: –0.32, p<.05), lower treatment 
control (M:9.66 vs. 10.04; ß: –0.36, p<.05), more negative appraisal of behavioural responses 
(M:12.27 vs. 12.85; ß: –0.56, p<.01), and higher risk perceptions (M:8.69 vs. 6.36; ß:2.26, p<.001).
Associations between subscales and lung cancer screening intention
With the exception of coherence and perceived stigma, all the constructs were statistically 
significantly associated with intention to be screened in analyses adjusted for demographic 
factors and smoking status (see Table 3). More positive perceptions of the consequences of 
lung cancer and the chance of survival, as well as the efficacy of early diagnosis and smoking 
cessation as behavioural responses, were associated with higher odds of intending to take 
part in screening (all p’s <.001). Similarly, higher perceived risk and perceived control (both 
personal and treatment) statistically significantly increased the likelihood of intending to 
Table 3. associations between the final measure constructs and intention to be screened.
By intention Unadjusted Adjusteda
Intend Do not intend oR (95% cI) significance oR (95% cI) significance
Subscales, mean (SD)
 consequences 4.49 (1.43) 5.34 (1.85) 0.72 (0.65, 0.80) <.001 0.73 (0.65, 0.82) <.001
 Personal control 11.20 (1.96) 10.13 (2.05) 1.28 (1.17, 1.41) <.001 1.26 (1.14, 1.40) <.001
 treatment control 9.97 (2.12) 8.69 (2.02) 1.32 (1.19, 1.45) <.001 1.31 (1.19, 1.46) <.001
 coherence 9.10 (2.45) 8.91 (2.24) 1.03 (0.96, 1.12) .421 1.03 (0.95, 1.12) .418
 emotional representation 7.30 (2.57) 8.36 (2.65) 0.86 (0.81, 0.92) <.001 0.85 (0.79, 0.91) <.001
 Behavioural response 12.82 (1.76) 9.40 (1.99) 2.60 (2.21, 3.06) <.001 2.58 (2.18, 3.05) <.001
 Risk perception 7.55 (2.53) 7.05 (2.44) 1.09 (1.00, 1.18) <.05 1.20 (1.09, 1.32) <.001
Single items, % (n)
Response efficacy of 
smoking cessation







































aModels adjusted for gender, age, socioeconomic position, marital status and smoking status.
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be screened (all p’s <.001). Willingness to be treated for early stage lung cancer had the 
largest positive effect estimate (aOR: 10.95; 95% CI: 7.05–17.02). Conversely, more positive 
emotional representations of lung cancer were associated with reduced odds of holding 
positive screening intentions (aOR: 0.85; 95% CI: 0.79–0.91).
Discussion
This paper describes the development of the first standardised measure of the psychological 
determinants of lung cancer screening participation by high-risk individuals: the Self-
Regulatory Questionnaire for Lung Cancer Screening (SRQ-LCS). The seven factor-derived 
subscales share a similar factor structure to the components of the SRM on which item 
generation was based, with four additional single-item constructs. All items retained for the 
final measure had superior psychometric properties when compared with the wider item 
pool with regards to their comprehensibility, response distributions, discriminant validity, 
internal reliability and construct validity. Nearly all the SRQ-LCS constructs were associated 
with intention to be screened for lung cancer, suggesting good discriminant validity for 
tfuture prospective studies of lung cancer screening uptake behaviour.
Most of the final constructs were associated with intention to be screened and smoking 
status in adjusted analyses, with comparatively fewer associations with demographic char-
acteristics. Many of these associations were largely as expected from prior literature. For 
example, current smokers have previously been found to hold higher lung cancer risk per-
ceptions when compared with former smokers, including both affective and comparative 
dimensions of risk perceptions (Ali et al., 2015; Quaife et al., 2018; Sach & Whynes, 2009). The 
finding of lower perceived personal control among current smokers and those of a lower 
SEP is also consistent with previous evidence that these groups more frequently report 
fatalistic perceptions about cancer (Miles et al., 2011; Quaife et al., 2015) and an external 
locus of control over their health (Poortinga et al., 2008). Women also reported lower per-
ceived personal control as well as higher risk perceptions compared with men, which is more 
challenging to explain. The latter may be due to the predominantly affective items within 
the risk perception sub-scale (e.g. ‘How often do you worry about lung cancer?’), with research 
showing that women tend to report higher cancer worry (Vrinten et al., 2014).
There were two seemingly counterintuitive associations. First, the finding that current 
smokers perceived the consequences of lung cancer relatively more positively than former 
smokers contrasts with previous studies (Quaife et al., 2018; Smits et al., 2018). One possible 
explanation is that the items comprising the consequences scale in the current study con-
cern different outcomes to that of survival which has most commonly been measured. It 
is possible that current smokers perceive these types of outcome (such as the impact on 
close others) relatively less negatively. However, the absolute difference in mean scores 
was small and means for both groups were within the lower (more negative) range of the 
scale. Alternatively, it is possible that current smokers downplay the consequences of lung 
cancer as a form of emotion-focussed coping. The second unexpected finding is that those 
with a higher (more positive) emotional representation score were less likely to intend to 
be screened. The Principal Components Analysis showed the risk perception, consequences 
and emotional representation components were distinct. Nevertheless, it is possible that 
participants’ perceived fear, anxiety and worry in response to thinking about lung cancer 
partly reflects their degree of personal concern about getting the disease and the personal 
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consequences of the disease. Those less concerned may in turn be less likely to intend to 
be screened. In both instances of these incongruous findings it is important to note that a 
central tenet of the SRM (see Figure 1) is that the relationships between constructs are 
bi-directional, with interactions between them explaining lung cancer screening behaviour. 
The individual must perceive a certain degree of risk in order for cognitive and emotional 
representations to be formed, and coping behaviours, to be enacted. Coping may aim to 
mitigate the risk of lung cancer mortality itself or may address the emotional response. In 
each case, appraisal will feed back into the representations and coping mechanisms. If 
perceived risk is too low, these reactions and responses may not be triggered. However, if 
perceived risk is too high, an adverse emotional response may trigger defensive processes 
if illness perceptions and coping behaviours are perceived negatively, which could attenuate 
the self-reported risk perception so that when measured, it appears low. The planned pro-
spective, longitudinal cohort study of lung cancer screening uptake for which this measure 
was developed, is designed to understand these interactions over time.
There were limitations to this study that restrict generalisation beyond the present sample. 
While the eligibility criteria for the online survey were based on the 2013 USPSTF screening 
criteria, participants are likely to be less diverse than the broader screening-eligible popu-
lation by virtue of the online mode. Indeed, there were very few participants in the lowest 
SEP group or from ethnic minority backgrounds. This further limits generalisability, especially 
given that those at highest risk of lung cancer are overrepresented within lower SEP groups. 
More diverse samples may report different structures of beliefs as has been found previously 
(Jonnalagadda et al., 2012). Therefore, while the SRQ-LCS’s validity was established within 
the present sample, as with any PCA, further research is needed to test whether the same 
factor structure is confirmed in other samples. A further limitation is the hypothetical nature 
of the outcome variable, screening intention. There exists a widely documented ‘inten-
tion-behaviour gap’ (Sheeran, 2002) whereby intentions can be an unreliable proxy for actual 
behaviour. Future research should test whether the SRQ-LCS is able to discriminate screening 
behaviour as well as screening intentions. In addition, the SRQ-LCS is focussed on measuring 
individual-level cognitive and affective perceptions of risk of lung cancer mortality and 
screening, but there are of course likely to be wider social, environmental and structural 
factors determining screening behaviour. Finally, all items assessing behavioural responses 
for controlling one’s emotional reaction to risk of lung cancer mortality (adapted from the 
brief COPE measure) were removed following cognitive interviewing because they lacked 
face validity, particularly when intended for a population of varying risk. However, this may 
have excluded an important construct which deserves further examination in future studies.
The SRQ-LCS appears to provide an acceptable, reliable and valid tool to measure and 
understand the interplay of psychological factors instrumental in determining lung cancer 
screening uptake. Using standardised measures should help build and progress scientific 
understanding in this field and ultimately provide a rigorous evidence-base from which to 
isolate psychological targets for intervention.
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